VitriVax
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5500 Central Ave Ste 220, Boulder, Color...Phone Number
(303) 578-2113Website
www.vitrivaxbio.comRevenue
$12.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About VitriVax
VitriVax is a biotech company developing thermostable, single-dose vaccines using its innovative ALTA® technology, aimed at improving global vaccine accessibility and efficacy.Explore more
VitriVax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VitriVax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at VitriVax
Funding: Get notified immidiatlly once VitriVax has new funding data
Website visits: Recent activity has been detected on your website
VitriVax, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if VitriVax is spiking on competitors!
Click to see if VitriVax had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if VitriVax has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when VitriVax launches new products
Earning: See what the market has to say on VitriVax recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to VitriVax
Compare insights from companies similar to VitriVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VitriVax is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VitriVax is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VitriVax.
VitriVax financials insights
Gather financial insights about VitriVax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Grant
$5M
2025
Series B
$17.3M
VitriVax Tech Stack
A closer look at the technologies used by VitriVax
Most Recent Scoops
Funding
Funding
Funding
Open Position
VitriVax is currently seeking an Director Cmc Development. (Boulder, CO)
Funding
VitriVax News & Media
VitriVax Awarded $3.6M Grant for Polio Vaccine Development
BOULDER, Colo.--(BUSINESS WIRE)--VitriVax Awarded $3.6M Grant from Gates Foundation for Polio Vaccine DevelopmentVitriVax Receives $5M Grant
VitriVax, a Boulder, CO-based formulation technology company, received $5M two-year grant from Bill & Melinda Gates Foundation. The grant will allow the company to develop further its proprietary single shot, thermostabilization vaccine technology (ALTA™) and begin the development of pilot-scale manufacturing capacity. Led by CEO Romulo Colindres, VitriVax has engineered its proprietary atomic layering thermostable […] The post VitriVax Receives $5M Grant appeared first on FinSMEs.VitriVax Receives $5M Grant for Vaccine Development
BOULDER, Colo.--(BUSINESS WIRE)--VitriVax, Inc., a formulation technology company, announced today a $5M two-year grant from the Bill & Melinda Gates Foundation. The grant will allow the company to develop further its proprietary single shot, thermostabilization vaccine technology (ALTA™) and begin the development of pilot-scale manufacturing capacity. As part of the grant, the company will study the ALTA™ mechanism of action using model antigens, such as those targeting HIV. The project wiVitriVax Awarded $29M DoD Contract to Fund Vaccine Research
BOULDER, Colo.--(BUSINESS WIRE)--VitriVax Inc., a formulation technology company, has been awarded a $29M five-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense. The overall objective of the research proposal titled “Optimization and Production of Single-Shot Vaccines for Melioidosis and Glanders” is to apply VitriVax’s single-shot and thermostabilization technology (ALTA™) to the lead B. pseudomallei (Bp) vaccine candidate, which is cu
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VitriVax
Sign Up For FreeTo access detailed company insights
VitriVax is a biotech company developing thermostable, single-dose vaccines using its innovative ALTA® technology, aimed at improving global vaccine accessibility and efficacy.... Read More
